中度至重度持续性支气管哮喘的临床试验
总计508个结果
-
Suzhou Connect Biopharmaceuticals, Ltd.完全的
-
Lu Yuan LeeNational Institute of Allergy and Infectious Diseases (NIAID)撤销
-
Beer, Kenneth R., M.D., PAMedicis Pharmaceutical Corporation完全的
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
University of California, San DiegoMayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); Yale University; Brigham and Women... 和其他合作者招聘中
-
Incyte Corporation招聘中中度至重度哮喘大韩民国, 美国, 西班牙, 波兰, 日本, 加拿大, 德国, 比利时, 阿根廷
-
Cytos Biotechnology AG终止
-
Tripler Army Medical CenterU.S. Army Medical Research Acquisition Activity未知Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines美国
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbH完全的
-
Novartis PharmaceuticalsGenentech, Inc.完全的
-
SamA Pharmaceutical Co., Ltd完全的
-
Wake Forest UniversityNational Heart, Lung, and Blood Institute (NHLBI)完全的